ASDDR, LLC

Biotech

HDAC inhibitor therapeutics for autism treatment, repurposing epigenetic drugs

Grants
$771K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
1 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Discovery of Novel Drugs for Autism$388,482
Federal grantDepartment of Health and Human Services · Phase I · Discovery of Novel Drugs for Autism$382,982
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3122Nami Therapeutics Corp.——
3123Silicon Insite, Inc.——
3124OncoSolutions LLC——
3125ASDDR, LLC——
3126ThirdLaw Technologies LLC——
3127AVANTYX, LLC——
3128MYRIEL, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 3

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.